African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12502

Full Length Research Paper

Expression of human β-defensin-1 in recombinant Escherichia coli and analysis of its antimicrobial spectrum

Myung-Ji Seo1#*, Hak-Jong Choi2#, Jung-Choul Lee3, Yu-Ryang Pyun3 and Hoon Park4
  1Fermentation and Functionality Research Group, Korea Food Research Institute, Sungnam 463-746, Republic of Korea. 2Department of Anatomy, Pusan National University School of Medicine, Yangsan 626-870, Republic of Korea. 3Department of Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea. 4Department of Food Science, Sunmoon University, Asan 336-708, Republic of Korea.
Email: [email protected]

  •  Accepted: 25 April 2012
  •  Published: 15 May 2012

Abstract

 

Escherichia coli BL21(DE3) was transformed with a pHCD1 plasmid harboring the human β-defensin-1 (hBD1) gene fused in frame behind a disulfide bond isomerase (DsbC), a His-tag, and an enterokinase cleavage site. After induction, the DsbC-hBD1 was expressed as a ~36 kDa soluble fusion protein in recombinant E. coli, which also inhibited host cell growth. After cell disruption, the soluble protein was easily recovered by Ni2+ affinity chromatography and cleaved by enterokinase to yield a mature hBD1 of about 4 kDa. Importantly, the mature hBD1 showed broad antimicrobial activity against Gram-positive and -negative pathogenic bacteria, including Streptococcus pneumoniaeE. coli O157:H7, and Klebsiella pneumoniae.

 

Key words: Antimicrobial activity, Escherichia coli, human β-defensin-1, soluble expression.

Abbreviation

hBD1, Human β-defensin-1; DsbC, disulfide bond isomerase.